Progress on SARS-CoV-2 3CLpro Inhibitors: Inspiration from SARS-CoV 3CLpro Peptidomimetics and Small-Molecule Anti-Inflammatory Compounds
Open Access
- 1 April 2022
- journal article
- review article
- Published by Taylor & Francis Ltd in Drug Design, Development and Therapy
- Vol. ume 16, 1067-1082
- https://doi.org/10.2147/dddt.s359009
Abstract
Dove Press is a member of the Open Access Initiative, specializing in peer reviewed Medical Journals. View articlesor submit your research for publishingKeywords
This publication has 89 references indexed in Scilit:
- Ligand docking and binding site analysis with PyMOL and Autodock/VinaJournal of Computer-Aided Molecular Design, 2010
- Mutation of Glu-166 Blocks the Substrate-Induced Dimerization of SARS Coronavirus Main ProteaseBiophysical Journal, 2010
- Mechanism for Controlling the Dimer-Monomer Switch and Coupling Dimerization to Catalysis of the Severe Acute Respiratory Syndrome Coronavirus 3C-Like ProteaseJournal of Virology, 2008
- Synthesis, Crystal Structure, Structure−Activity Relationships, and Antiviral Activity of a Potent SARS Coronavirus 3CL Protease InhibitorJournal of Medicinal Chemistry, 2006
- Bats Are Natural Reservoirs of SARS-Like CoronavirusesScience, 2005
- Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main ProteasesPLoS Biology, 2005
- Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS DrugsScience, 2003
- The Genome Sequence of the SARS-Associated CoronavirusScience, 2003
- Refined X-ray crystallographic structure of the poliovirus 3C gene productJournal of Molecular Biology, 1997
- Modulation of Cytokine Production by a Selenoorganic Compound (AE-22) in Hyperreactive or Hyporeactive Bronchoalveolar Leukocytes of Asthmatics or Lung Cancer PatientsJournal of Interferon & Cytokine Research, 1997